NO20025134D0 - Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjonhos pattedyr - Google Patents

Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjonhos pattedyr

Info

Publication number
NO20025134D0
NO20025134D0 NO20025134A NO20025134A NO20025134D0 NO 20025134 D0 NO20025134 D0 NO 20025134D0 NO 20025134 A NO20025134 A NO 20025134A NO 20025134 A NO20025134 A NO 20025134A NO 20025134 D0 NO20025134 D0 NO 20025134D0
Authority
NO
Norway
Prior art keywords
mammals
bacterial
prevention
treatment
protozoal infections
Prior art date
Application number
NO20025134A
Other languages
English (en)
Other versions
NO20025134L (no
Inventor
Wayne Alan Boettner
Peter Connor Canning
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20025134D0 publication Critical patent/NO20025134D0/no
Publication of NO20025134L publication Critical patent/NO20025134L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20025134A 2000-04-27 2002-10-25 Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr NO20025134L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27
PCT/IB2001/000519 WO2001081358A1 (en) 2000-04-27 2001-03-26 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals

Publications (2)

Publication Number Publication Date
NO20025134D0 true NO20025134D0 (no) 2002-10-25
NO20025134L NO20025134L (no) 2002-12-19

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025134A NO20025134L (no) 2000-04-27 2002-10-25 Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr

Country Status (30)

Country Link
US (2) US20020019353A1 (no)
EP (1) EP1276747A1 (no)
JP (1) JP2004516233A (no)
KR (1) KR20030031479A (no)
CN (1) CN1227258C (no)
AP (1) AP2002002652A0 (no)
AR (1) AR028041A1 (no)
AU (1) AU4269301A (no)
BG (1) BG107168A (no)
BR (1) BR0110382A (no)
CA (1) CA2407448A1 (no)
CZ (1) CZ20023409A3 (no)
EA (1) EA200200995A1 (no)
GT (1) GT200100063A (no)
HU (1) HUP0300585A3 (no)
IL (1) IL152421A0 (no)
IS (1) IS6559A (no)
MA (1) MA26896A1 (no)
MX (1) MXPA02010586A (no)
NO (1) NO20025134L (no)
OA (1) OA12257A (no)
PA (1) PA8515601A1 (no)
PE (1) PE20011188A1 (no)
PL (1) PL359861A1 (no)
SK (1) SK14882002A3 (no)
TN (1) TNSN01063A1 (no)
UY (1) UY26678A1 (no)
WO (1) WO2001081358A1 (no)
YU (1) YU78702A (no)
ZA (1) ZA200208603B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
US8314071B2 (en) 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
WO2014004761A2 (en) * 2012-06-27 2014-01-03 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
US20180168196A1 (en) 2016-12-15 2018-06-21 Nestec Sa Compositions and methods that modulate bacteria in a companion animal
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CA3054023A1 (en) * 2017-02-22 2018-08-30 Immune System Regulation Holding Ab Novel immune stimulating macrolides
EP3883647A1 (en) * 2018-11-19 2021-09-29 Zikani Therapeutics, Inc. C10-alkylene substituted 13-membered macrolides and uses thereof
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
CA3231535A1 (en) * 2021-09-07 2023-03-16 Zoetis Services Llc Immunomodulating azalides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
MA26896A1 (fr) 2004-12-20
HUP0300585A3 (en) 2003-09-29
US20040235759A1 (en) 2004-11-25
MXPA02010586A (es) 2003-03-10
KR20030031479A (ko) 2003-04-21
BG107168A (bg) 2003-07-31
IS6559A (is) 2002-09-20
BR0110382A (pt) 2003-06-24
PA8515601A1 (es) 2002-07-30
EP1276747A1 (en) 2003-01-22
NO20025134L (no) 2002-12-19
WO2001081358A1 (en) 2001-11-01
SK14882002A3 (en) 2004-11-03
AU4269301A (en) 2001-11-07
UY26678A1 (es) 2001-12-28
AR028041A1 (es) 2003-04-23
YU78702A (sh) 2005-11-28
PL359861A1 (en) 2004-09-06
OA12257A (en) 2003-11-06
AP2002002652A0 (en) 2002-12-31
EA200200995A1 (ru) 2003-04-24
US20020019353A1 (en) 2002-02-14
ZA200208603B (en) 2003-10-24
JP2004516233A (ja) 2004-06-03
CN1227258C (zh) 2005-11-16
CA2407448A1 (en) 2001-11-01
HUP0300585A2 (hu) 2003-06-28
TNSN01063A1 (fr) 2005-11-10
CN1429232A (zh) 2003-07-09
PE20011188A1 (es) 2001-11-24
CZ20023409A3 (cs) 2004-01-14

Similar Documents

Publication Publication Date Title
NO20025134D0 (no) Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjonhos pattedyr
IT1306716B1 (it) Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
ZA200507070B (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
GB0125222D0 (en) Composition for the treatment of microbial infections
PT956858E (pt) Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
EP1594444A3 (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
WO2004087145A3 (en) Antibacterial agents
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
WO2004058144A3 (en) Antibacterial agents
MY139124A (en) Gyrase inhibitors and uses thereof
WO2004041210A3 (en) Antibacterial agents
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
NO20015464L (no) Attenuerte mikroorganismer for behandling av infeksjon
NO20013964D0 (no) Spontant dispergerbare N-benzoyl staurosporin-sammensetninger
WO2004096982A3 (en) Antibacterial agents
DK1216256T3 (da) Makrolid-antibiotika og behandling af pasteurellosis
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
NO20042199L (no) Lav peroksydkonsentrasjon for behandling eller forebygging av vaginale infeksjoner
EP1114826A3 (en) Novel antibacterial and prokinetic macrolides
CA2332686A1 (en) Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
PT1200605E (pt) Gene de streptomyces avermitilis controlador da proporcao de avermectinas b2:b1
WO2002057281A3 (en) Aminoglycosides as antibiotics

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application